Dr. Brij Mohan Makkar | Diabetes and Endocrinology | Omnicuris

Verifying...

Loading, please wait...

Dr. Brij Mohan Makkar | Diabetes and Endocrinology | Omnicuris

Dr. Brij Mohan Makkar

Medical Expert

Qualification

Diabetes and Endocrinology

Location

Delhi, IN

Qualification

Diabetes and Endocrinology

Location

Delhi, IN

Educational Content

32 Sessions

SGLT2 Inhibitor - On Cardiovascular and Renal Events in Patients with Type 2 Diabetes

SGLT2 Inhibitor - On Cardiovascular and Renal Events in Patients with Type 2 Diabetes

SGLT2 Inhibition - Potential Clinical Benefits with Case Histories

SGLT2 Inhibition - Potential Clinical Benefits with Case Histories

Obesity Management

Obesity Management

Hyperglycemic Management in Obese Patients

Hyperglycemic Management in Obese Patients

Prevalence of Obesity and Diabetes in India

Prevalence of Obesity and Diabetes in India

Insulin therapy ; Initiation, Problems & Strategies

Insulin therapy ; Initiation, Problems & Strategies

Insulin : Introduction, Role Of Insulin & Its Pathways

Insulin : Introduction, Role Of Insulin & Its Pathways

Treatment Strategies For Obese Patients With T2DM

Treatment Strategies For Obese Patients With T2DM

Nutritional Approaches in the Treatment of Diabetes and Metabolic Syndrome

Nutritional Approaches in the Treatment of Diabetes and Metabolic Syndrome

Question and Answer

Question and Answer

Role of Micronutrients, Vitamins, and Antioxidants in Health and Disease

Role of Micronutrients, Vitamins, and Antioxidants in Health and Disease

Understanding Diabesity and It's Treatment Options

Understanding Diabesity and It's Treatment Options

D3 MV Discussion 3

D3 MV Discussion 3

Medical Management of Obesity: What Are the Options?

Medical Management of Obesity: What Are the Options?

FDC combination of Remogliflozin + Vildagliptin + Metformin

FDC combination of Remogliflozin + Vildagliptin + Metformin

Metformin in Pregnancy : Yes / No

Metformin in Pregnancy : Yes / No

Importance of Treating Dyslipidemia Patients

Importance of Treating Dyslipidemia Patients

Dapagliflozin in respiratory failure in patients with Covid-19

Dapagliflozin in respiratory failure in patients with Covid-19

SGLT2 Inhibitor - On Cardiovascular and Renal Events in Patients with Type 2 Diabetes

SGLT2 Inhibitor - On Cardiovascular and Renal Events in Patients with Type 2 Diabetes

SGLT2 Inhibition - Potential Clinical Benefits with Case Histories

SGLT2 Inhibition - Potential Clinical Benefits with Case Histories

Panel Discussion 1

Panel Discussion 1

SMBG: Current Usage & Guidelines

SMBG: Current Usage & Guidelines

Role of Saroglitazar in the management of Diabetic Dyslipidemia - An update

Role of Saroglitazar in the management of Diabetic Dyslipidemia - An update

Anti-obesity drugs – evidence and safety

Anti-obesity drugs – evidence and safety

Alogliptin- A new CV safe gliptin in India

Alogliptin- A new CV safe gliptin in India

RSSDI Consensus Guideline

RSSDI Consensus Guideline

Obesity Management

Obesity Management

Hyperglycemic Management in Obese Patients

Hyperglycemic Management in Obese Patients

Prevalence of Obesity and Diabetes in India

Prevalence of Obesity and Diabetes in India

Treatment Strategies For Obese Patients With T2DM

Treatment Strategies For Obese Patients With T2DM

Insulin therapy ; Initiation, Problems & Strategies

Insulin therapy ; Initiation, Problems & Strategies

Insulin : Introduction, Role Of Insulin & Its Pathways

Insulin : Introduction, Role Of Insulin & Its Pathways